| Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19) C Agrati, A Sacchi, V Bordoni, E Cimini, S Notari, G Grassi, R Casetti, ... Cell Death & Differentiation 27 (11), 3196-3207, 2020 | 235 | 2020 |
| Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases R Carsetti, S Zaffina, E Piano Mortari, S Terreri, F Corrente, C Capponi, ... Frontiers in immunology 11, 610300, 2020 | 184 | 2020 |
| Unique human immune signature of Ebola virus disease in Guinea P Ruibal, L Oestereich, A Lüdtke, B Becker-Ziaja, DM Wozniak, R Kerber, ... Nature 533 (7601), 100-104, 2016 | 181 | 2016 |
| Humoral-and T-cell–specific immune responses to SARS-CoV-2 mRNA vaccination in patients with MS using different disease-modifying therapies C Tortorella, A Aiello, C Gasperini, C Agrati, C Castilletti, S Ruggieri, ... Neurology 98 (5), e541-e554, 2022 | 145 | 2022 |
| An inflammatory profile correlates with decreased frequency of cytotoxic cells in coronavirus disease 2019 V Bordoni, A Sacchi, E Cimini, S Notari, G Grassi, E Tartaglia, R Casetti, ... Clinical Infectious Diseases 71 (16), 2272-2275, 2020 | 108 | 2020 |
| Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome A Sacchi, G Grassi, V Bordoni, P Lorenzini, E Cimini, R Casetti, ... Cell death & disease 11 (10), 921, 2020 | 104 | 2020 |
| ImmunosuppressiveTherapies differently modulate Humoral-and T-cell-specific responses to COVID-19 mRNA vaccine in rheumatoid arthritis patients A Picchianti-Diamanti, A Aiello, B Laganà, C Agrati, C Castilletti, S Meschi, ... Frontiers in immunology 12, 740249, 2021 | 82 | 2021 |
| Humoral and cellular immune response elicited by mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in people living with human … A Antinori, S Cicalini, S Meschi, V Bordoni, P Lorenzini, A Vergori, ... Clinical Infectious Diseases 75 (1), e552-e563, 2022 | 71 | 2022 |
| Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV A Vergori, A Cozzi Lepri, S Cicalini, G Matusali, V Bordoni, S Lanini, ... Nature Communications 13 (1), 4922, 2022 | 68 | 2022 |
| Activated Vγ9Vδ2 T cells trigger granulocyte functions via MCP-2 release C Agrati, E Cimini, A Sacchi, V Bordoni, C Gioia, R Casetti, F Turchi, ... The Journal of Immunology 182 (1), 522-529, 2009 | 65 | 2009 |
| Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection C Agrati, C Castilletti, R Casetti, A Sacchi, L Falasca, F Turchi, N Tumino, ... Cell death & disease 7 (3), e2164-e2164, 2016 | 64 | 2016 |
| Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course C Agrati, C Gioia, E Lalle, E Cimini, C Castilletti, O Armignacco, FN Lauria, ... The Journal of infectious diseases 202 (5), 681-689, 2010 | 63 | 2010 |
| In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3ζ expression through ELF-1 inhibition N Tumino, F Turchi, S Meschi, E Lalle, V Bordoni, R Casetti, C Agrati, ... Aids 29 (18), 2397-2407, 2015 | 60 | 2015 |
| COVID‐19 in people living with HIV: clinical implications of dynamics of the immune response to SARS‐CoV‐2 A Mondi, E Cimini, F Colavita, S Cicalini, C Pinnetti, G Matusali, R Casetti, ... Journal of medical virology 93 (3), 1796-1804, 2021 | 55 | 2021 |
| Hepatitis C virus direct‐acting antivirals therapy impacts on extracellular vesicles microRNAs content and on their immunomodulating properties L Santangelo, V Bordoni, C Montaldo, E Cimini, A Zingoni, C Battistelli, ... Liver International 38 (10), 1741-1750, 2018 | 50 | 2018 |
| Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections E Cimini, D Viola, M Cabeza-Cabrerizo, A Romanelli, N Tumino, A Sacchi, ... PLoS Neglected Tropical Diseases 11 (5), e0005645, 2017 | 49 | 2017 |
| The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients V Bordoni, E Tartaglia, A Sacchi, GM Fimia, E Cimini, R Casetti, S Notari, ... International Journal of Infectious Diseases 105, 49-53, 2021 | 44 | 2021 |
| Expansion of myeloid derived suppressor cells contributes to platelet activation by L-arginine deprivation during SARS-CoV-2 infection A Sacchi, G Grassi, S Notari, S Gili, V Bordoni, E Tartaglia, R Casetti, ... Cells 10 (8), 2111, 2021 | 42 | 2021 |
| Human Zika infection induces a reduction of IFN-γ producing CD4 T-cells and a parallel expansion of effector Vδ2 T-cells E Cimini, C Castilletti, A Sacchi, R Casetti, V Bordoni, A Romanelli, ... Scientific reports 7 (1), 6313, 2017 | 41 | 2017 |
| Myeloid-derived suppressor cells specifically suppress IFN-γ production and antitumor cytotoxic activity of Vδ2 T cells A Sacchi, N Tumino, A Sabatini, E Cimini, R Casetti, V Bordoni, G Grassi, ... Frontiers in immunology 9, 368341, 2018 | 40 | 2018 |
